Inventor

THROSBY MARK

NL48 patents

⚠️ This page may combine multiple inventors who share the name “THROSBY MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THROSBY MARK

MERUS NV

Antibody producing non-human animals

Antibody that binds ErbB-2 and ErbB-3

Antibody producing non-human animals

Antibodies that bind EGFR and ErbB3

Generation of binding molecules

Antibody that binds ErbB-2 and ErbB-3

ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor

Bispecific anti PD1-anti TIM3 antibodies

Antibodies that modulate a biological activity expressed by a cell

Binding molecules that modulate a biological activity expressed by a cell

Generation of binding molecules

Antibody producing non-human animals

Binding molecules that inhibit cancer growth

Antibody producing non-human animals

Bispecific anti PD1-anti TIM3 antibodies

Generation of binding molecules

Binding molecules that bind CD137 and PD-L1

TGF-beta-RII binding proteins

Antibodies that bind EGFR and cMET

CRUCELL HOLLAND BV

Human binding molecules having killing activity against enterococci and uses thereof

Host cell specific binding molecules capable of neutralizing viruses and uses thereof

Binding molecules capable of neutralizing West Nile virus and uses thereof

Human binding molecule against CD1a

Human binding molecules having killing activity against enterococci

Binding molecules capable of neutralizing west nile virus and uses thereof

Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

THROSBY MARK

Host cell specific binding molecules capable of neutralizing viruses and uses thereof

Human binding molecules having killing activity against enterococci and uses thereof

Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof

Human binding molecules having killing activity against staphylococci and uses thereof

Method for preparing immunoglobulin libraries

Human binding molecules against enterococci and Staphylococcus

Human binding molecules having killing activity against staphylococci and uses thereof

MERUS B V

Generation of binding molecules

Antibody producing non-human mammals

Antibody producing non-human mammals

Generation of binding molecules

VAN DEN BRINK EDWARD NORBERT

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

ONO PHARMACEUTICAL CO

Bispecific antibody

Bispecific antibody

Bispecific antibody

LOGTENBERG TON

Antibody producing non-human mammals